SCHEMBL1683378

SCHEMBL1683378

Cc1c(Cl)c(Cl)cc(O)c1Cc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.47
MEN1 O00255 5/20 0.47
MAPT P10636 4/20 0.47
ALOX5 P09917 2/20 0.41
ALOX15 P16050 3/20 0.41
IGF1R P08069 1/20 0.41
LMNA P02545 5/20 0.40
CYP3A4 P08684 4/20 0.40
HPGD P15428 4/20 0.40
HSD17B10 Q99714 3/20 0.40
HIF1A Q16665 2/20 0.40
POLB P06746 1/20 0.40
AKR1B1 P15121 1/20 0.39
HTT P42858 3/20 0.39
SLC22A1 O15245 1/20 0.39
USP2 O75604 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSPD1 P10809 1/20 0.39
HSPA5 P11021 1/20 0.39
IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3989555 0.75 KMT2A (0.49) KMT2AMEN1MAPTALOX5ALOX15
SCHEMBL11254330 0.75 MEN1 (0.49) KMT2AMEN1MAPTALOX15IGF1R
SCHEMBL9192605 0.73 KMT2A (0.47) KMT2AMEN1MAPTLMNAIDO1
SCHEMBL1550879 0.73 ALOX5 (0.46) KMT2AMEN1MAPTALOX5ALOX15
SCHEMBL1683379 0.71 MAPT (0.53) KMT2AMEN1MAPTALOX5ALOX15
SCHEMBL9185748 0.71 KMT2A (0.43) KMT2AMEN1MAPTCYP3A4HIF1A
SCHEMBL20164913 0.70 MEN1 (0.41) KMT2AMEN1MAPTALOX5ALOX15
Parachlorophenol SCHEMBL6914323 0.70 MEN1 (0.47) KMT2AMEN1MAPTALOX5ALOX15
SCHEMBL11260186 0.69 MEN1 (0.65) KMT2AMEN1MAPTALOX15IGF1R
Clorophene SCHEMBL8335308 0.69 MEN1 (0.70) KMT2AMEN1MAPTALOX5ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086823-A1 DISINFECTANT BAYER ANIMAL HEALTH GMBH (DE) 2011-04-14 US claimed
US-20080221222-A1 Disinfectant BAYER HEALTHCARE LLC (DE) 2008-09-11 US claimed
US-8440612-B2 Controlling giardiosis BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-14 US disclosed
US-20110168623-A1 FEED SIDE PASSAGE MATERIAL AND SPIRAL SEPARATION MEMBRANE ELEMENT NITTO DENKO CORPORATION (JP) 2011-07-14 US disclosed
US-20110105388-A1 NOVEL POSSIBILITY OF CONTROLLING GIARDIOSIS BAYER ANIMAL HEALTH GMBH (DE) 2011-05-05 US disclosed
US-20110086823-A1 DISINFECTANT BAYER ANIMAL HEALTH GMBH (DE) 2011-04-14 US disclosed
US-20080221222-A1 Disinfectant BAYER HEALTHCARE LLC (DE) 2008-09-11 US disclosed
US-5620655-A MIXTURE OF A PHENOL COMPOUND AND ORGANIC ACID MENNO-CHEMIE-VERTRIEB GMBH (DE) 1997-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105388-A1 NOVEL POSSIBILITY OF CONTROLLING GIARDIOSIS TNNI3, PIGO, GLRX3 KMT2A 3316/4885MEN1 2736/4885MAPT 4798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.